USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18108
Title: Acute disseminated encephalomyelitis with bilateral optic nerve involvement
Authors: Goncearova, Natalia
Calugareanu, Elena
Cernei, Irina
Keywords: encephalomyelitis;demyelination;antibodies;immunotherapy
Issue Date: 2021
Publisher: The Scientific Medical Association of the Republic of Moldova
Citation: GONCEAROVA, Natalia, CALUGAREANU, Elena, CERNEI, Irina. Acute disseminated encephalomyelitis with bilateral optic nerve involvement. In: The Moldovan Medical Journal. 2021, vol. 64, no 3 (Neuro Congress Issue), p. 41. ISSN 2537-6381.
Abstract: Background: Acute disseminated encephalomyelitis (ADEM), possibly demyelinating is an acute, rapidly progressive autoimmune process characterized by CNS demyelination (frequently associated with involvement of optic nerves) due to immune-mediated inflammation, which requires rapid diagnosis and selection of appropriate early treatment. The aim of the studywas to present an unusual case of ADEM with bilateral involvement of optic nerves. Material and methods: A case study presentation. Results: Case report study of a 47-year-old man presented with progressive loss of vision in both eyes, numbness in the upper and lower limbs, static and gait disorders, urinary retention. The clinical onset was preceded by a Covid-19 infection 3 weeks before presentation. ENG demonstrated sensitive axonal polyneuropathy, brain MRI – demyelination in left frontal lobe area; cervical and thoracic contrast MRI – without pathological changes, visual evoked potentials results suggestive of prechiasmic demyelinating involvement on the right side, lumbar puncture – impossible to perform, ophthalmological examination – neuroophthalmopathy of unknown etiology, anti-MOG, anti-AQP4 antibodies – negative. Progressive evolution of the disease, following the first-line treatment (Prednizolon 500 mg, N8) and plasmapheresis. Home discharge with second-line treatment with Azathioprine 50 mg without positive dynamics. Conclusions: The presented case of ADEM proved no therapeutic effects to plasmapheresis and immunosuppressive treatment in spite of its autoimmune pathogenesis. Other therapy options to be considered: mofetil mycophenolate, IV IG, calcineurin inhibitors or other immunomodulatory agents.
metadata.dc.relation.ispartof: The Moldovan Medical Journal
URI: http://moldmedjournal.md/wp-content/uploads/2021/09/Congres-Neuro-2021-Spaltul-11.pdf
http://repository.usmf.md/handle/20.500.12710/18108
ISSN: 2537-6381
2537-6373
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 3, September 2021



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback